111 related articles for article (PubMed ID: 26230757)
1. Analysis of the binding mode of laulimalide to microtubules: Establishing a laulimalide-tubulin pharmacophore.
Churchill CD; Klobukowski M; Tuszynski JA
J Biomol Struct Dyn; 2016 Jul; 34(7):1455-69. PubMed ID: 26230757
[TBL] [Abstract][Full Text] [Related]
2. The Unique Binding Mode of Laulimalide to Two Tubulin Protofilaments.
Churchill CD; Klobukowski M; Tuszynski JA
Chem Biol Drug Des; 2015 Aug; 86(2):190-9. PubMed ID: 25376845
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of the laulimalide-microtubule binding mode by mass shift perturbation mapping.
Bennett MJ; Barakat K; Huzil JT; Tuszynski J; Schriemer DC
Chem Biol; 2010 Jul; 17(7):725-34. PubMed ID: 20659685
[TBL] [Abstract][Full Text] [Related]
4. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
[TBL] [Abstract][Full Text] [Related]
5. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of microtubule stabilization by laulimalide and peloruside A.
Prota AE; Bargsten K; Northcote PT; Marsh M; Altmann KH; Miller JH; Díaz JF; Steinmetz MO
Angew Chem Int Ed Engl; 2014 Feb; 53(6):1621-5. PubMed ID: 24470331
[TBL] [Abstract][Full Text] [Related]
7. Structural investigations into the binding mode of novel neolignans Cmp10 and Cmp19 microtubule stabilizers by in silico molecular docking, molecular dynamics, and binding free energy calculations.
Tripathi S; Kumar A; Kumar BS; Negi AS; Sharma A
J Biomol Struct Dyn; 2016 Jun; 34(6):1232-40. PubMed ID: 26212016
[TBL] [Abstract][Full Text] [Related]
8. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
[TBL] [Abstract][Full Text] [Related]
9. Modulation of lateral and longitudinal interdimeric interactions in microtubule models by Laulimalide and Peloruside A association: A molecular modeling approach on the mechanism of microtubule stabilizing agents.
Zúñiga MA; Alderete JB; Jaña GA; Fernandez PA; Ramos MJ; Jiménez VA
Chem Biol Drug Des; 2018 May; 91(5):1042-1055. PubMed ID: 29316292
[TBL] [Abstract][Full Text] [Related]
10. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.
Khrapunovich-Baine M; Menon V; Yang CP; Northcote PT; Miller JH; Angeletti RH; Fiser A; Horwitz SB; Xiao H
J Biol Chem; 2011 Apr; 286(13):11765-78. PubMed ID: 21245138
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of peloruside A by microtubules. The C24 primary alcohol is essential for biological activity.
Pera B; Razzak M; Trigili C; Pineda O; Canales A; Buey RM; Jiménez-Barbero J; Northcote PT; Paterson I; Barasoain I; Díaz JF
Chembiochem; 2010 Aug; 11(12):1669-78. PubMed ID: 20665616
[TBL] [Abstract][Full Text] [Related]
12. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
Mooberry SL; Tien G; Hernandez AH; Plubrukarn A; Davidson BS
Cancer Res; 1999 Feb; 59(3):653-60. PubMed ID: 9973214
[TBL] [Abstract][Full Text] [Related]
13. Wangzaozin A, a potent novel microtubule stabilizer, targets both the taxane and laulimalide sites on β-tubulin through molecular dynamics simulations.
Yang MH; Mao J; Zhu JH; Zhang H; Ding L
Life Sci; 2022 Jul; 301():120583. PubMed ID: 35504334
[TBL] [Abstract][Full Text] [Related]
14. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
Gapud EJ; Bai R; Ghosh AK; Hamel E
Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
[TBL] [Abstract][Full Text] [Related]
15. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
Kanakkanthara A; Wilmes A; O'Brate A; Escuin D; Chan A; Gjyrezi A; Crawford J; Rawson P; Kivell B; Northcote PT; Hamel E; Giannakakou P; Miller JH
Mol Cancer Ther; 2011 Aug; 10(8):1419-29. PubMed ID: 21653684
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
[TBL] [Abstract][Full Text] [Related]
17. Laulimalide and synthetic laulimalide analogues are synergistic with paclitaxel and 2-methoxyestradiol.
Clark EA; Hills PM; Davidson BS; Wender PA; Mooberry SL
Mol Pharm; 2006; 3(4):457-67. PubMed ID: 16889440
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.
Yadava U; Gupta H; Roychoudhury M
J Biol Phys; 2015 Mar; 41(2):117-33. PubMed ID: 25542396
[TBL] [Abstract][Full Text] [Related]
19. Microtubule-stabilizing agents based on designed laulimalide analogues.
Mooberry SL; Randall-Hlubek DA; Leal RM; Hegde SG; Hubbard RD; Zhang L; Wender PA
Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8803-8. PubMed ID: 15161976
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the covalent binding of zampanolide and taccalonolide AJ to a minimalist representation of a human microtubule.
Sánchez-Murcia PA; Mills A; Cortés-Cabrera Á; Gago F
J Comput Aided Mol Des; 2019 Jul; 33(7):627-644. PubMed ID: 31152293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
